• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨关节炎研究中优化多维有序MRI数据分析的方法:一种观点。

Approaches to optimize analyses of multidimensional ordinal MRI data in osteoarthritis research: A perspective.

作者信息

Collins Jamie E, Roemer Frank W, Guermazi Ali

机构信息

Orthopaedics and Arthritis Center of Outcomes Research, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, BTM Suite 5016, Boston, MA, 02115, USA.

Quantitative Imaging Center, Department of Radiology, Boston University School of Medicine, 820 Harrison Avenue, FGH Building, 4th Floor, Boston, MA, 02118, USA.

出版信息

Osteoarthr Cartil Open. 2024 Mar 27;6(2):100465. doi: 10.1016/j.ocarto.2024.100465. eCollection 2024 Jun.

DOI:10.1016/j.ocarto.2024.100465
PMID:38601258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11004399/
Abstract

OBJECTIVE

Knee osteoarthritis (OA) is a disease of the whole joint involving multiple tissue types. MRI-based semi-quantitative (SQ) scoring of knee OA is a method to perform multi-tissue joint assessment and has been shown to be a valid and reliable way to measure structural multi-tissue involvement and progression of the disease. While recent work has described how SQ scoring may be used for clinical trial enrichment and disease phenotyping in OA, less guidance is available for how these parameters may be used to assess study outcomes.

DESIGN

Here we present recommendations for summarizing disease progression within specific tissue types. We illustrate how various methods may be used to quantify longitudinal change using SQ scoring and review examples from the literature.

RESULTS

Approaches to quantify longitudinal change across subregions include the count of number of subregions, delta-subregion, delta-sum, and maximum grade changes. Careful attention should be paid to features that may fluctuate, such as bone marrow lesions, or with certain interventions, for example pharmacologic interventions with anticipated cartilage anabolic effects. The statistical approach must align with the nature of the outcome.

CONCLUSIONS

SQ scoring presents a way to understand disease progression across the whole joint. As OA is increasingly recognized as a heterogeneous disease with different phenotypes a better understanding of longitudinal progression across tissue types may present an opportunity to match study outcome to patient phenotype or to treatment mechanism of action.

摘要

目的

膝关节骨关节炎(OA)是一种累及多种组织类型的全关节疾病。基于磁共振成像(MRI)的膝关节OA半定量(SQ)评分是一种进行多组织关节评估的方法,已被证明是测量疾病结构多组织受累情况及进展的有效且可靠的方式。虽然近期研究描述了SQ评分如何用于OA的临床试验富集和疾病表型分析,但对于如何使用这些参数评估研究结果的指导较少。

设计

在此,我们提出关于总结特定组织类型内疾病进展的建议。我们举例说明如何使用各种方法通过SQ评分量化纵向变化,并回顾文献中的实例。

结果

量化跨子区域纵向变化的方法包括子区域数量计数、子区域差值、总和差值以及最大分级变化。应特别关注可能波动的特征,如骨髓病变,或在某些干预措施下,例如具有预期软骨合成代谢作用的药物干预。统计方法必须与结果的性质相符。

结论

SQ评分提供了一种了解全关节疾病进展的方法。由于OA越来越被认为是一种具有不同表型的异质性疾病,更好地理解跨组织类型的纵向进展可能为使研究结果与患者表型或治疗作用机制相匹配提供契机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/8a689c41b11d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/865e56631db1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/bc0a802ea551/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/8a689c41b11d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/865e56631db1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/bc0a802ea551/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/11004399/8a689c41b11d/gr3.jpg

相似文献

1
Approaches to optimize analyses of multidimensional ordinal MRI data in osteoarthritis research: A perspective.骨关节炎研究中优化多维有序MRI数据分析的方法:一种观点。
Osteoarthr Cartil Open. 2024 Mar 27;6(2):100465. doi: 10.1016/j.ocarto.2024.100465. eCollection 2024 Jun.
2
A perspective on the evolution of semi-quantitative MRI assessment of osteoarthritis: Past, present and future.骨关节炎半定量MRI评估的演变视角:过去、现在与未来
Osteoarthritis Cartilage. 2024 Apr;32(4):460-472. doi: 10.1016/j.joca.2024.01.001. Epub 2024 Jan 10.
3
An illustrative overview of semi-quantitative MRI scoring of knee osteoarthritis: lessons learned from longitudinal observational studies.膝关节骨关节炎半定量MRI评分的示例概述:纵向观察性研究的经验教训
Osteoarthritis Cartilage. 2016 Feb;24(2):274-89. doi: 10.1016/j.joca.2015.08.011. Epub 2015 Aug 28.
4
Magnetic resonance imaging-based semiquantitative and quantitative assessment in osteoarthritis.基于磁共振成像的骨关节炎半定量和定量评估。
Rheum Dis Clin North Am. 2009 Aug;35(3):521-55. doi: 10.1016/j.rdc.2009.08.006.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.司帕明对膝关节骨关节炎的结构影响:一项随机对照试验中软骨和非软骨组织改变的事后分析
BMC Musculoskelet Disord. 2016 Jul 9;17:267. doi: 10.1186/s12891-016-1128-2.
7
Examining a whole-organ magnetic resonance imaging scoring system for osteoarthritis of the knee using Rasch analysis.使用拉施分析检验膝关节骨关节炎的全器官磁共振成像评分系统。
Osteoarthritis Cartilage. 2006;14 Suppl A:A116-21. doi: 10.1016/j.joca.2006.03.011. Epub 2006 May 5.
8
How to define subregional osteoarthritis progression using semi-quantitative MRI osteoarthritis knee score (MOAKS).如何使用半定量 MRI 膝关节骨关节炎评分(MOAKS)定义亚区骨关节炎进展。
Osteoarthritis Cartilage. 2014 Oct;22(10):1533-6. doi: 10.1016/j.joca.2014.06.022.
9
The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score).一种用于膝关节骨关节炎MRI的新评分系统的可靠性及骨髓病变评估的有效性:BLOKS(波士顿-利兹膝关节骨关节炎评分)
Ann Rheum Dis. 2008 Feb;67(2):206-11. doi: 10.1136/ard.2006.066183. Epub 2007 May 1.
10
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.关于使用新方法评估改善病情药物治疗骨关节炎疗效的建议。
Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. doi: 10.1016/j.joca.2004.01.006.

引用本文的文献

1
Capturing deep partial-thickness cartilage loss with semiquantitative scoring: A supplemented MRI Osteoarthritis Knee Score (sMOAKS).通过半定量评分捕捉深度部分厚度软骨损伤:补充性MRI膝关节骨关节炎评分(sMOAKS)。
Osteoarthr Imaging. 2025 Jun 7. doi: 10.1016/j.ostima.2025.100272.
2
Multifaceted imaging strategies for clinical trials of knee osteoarthritis-a tightly interlinked value and precision chain.膝关节骨关节炎临床试验的多维度成像策略——一个紧密相连的价值与精准链条。
Skeletal Radiol. 2025 Apr 1. doi: 10.1007/s00256-025-04919-0.
3
Which Endpoints Should be Applied in Interventional Trials? -: From Single Uni-dimensional Assessment Tailored to a Drug's Mechanism of Action to Multi-Component Measures and Multi-Domain Composites.

本文引用的文献

1
Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures.在分析相关数据、聚类数据或重复测量数据时避免错误。
J Rheumatol. 2023 Oct;50(10):1269-1272. doi: 10.3899/jrheum.2022-1109. Epub 2023 May 15.
2
Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression.影像学在DMOAD临床试验中的策略性应用:聚焦于纳入标准、药物递送及结构进展的半定量评估。
Ther Adv Musculoskelet Dis. 2023 Apr 10;15:1759720X231165558. doi: 10.1177/1759720X231165558. eCollection 2023.
3
Worsening of Articular Tissue Damage as Defined by Semi-Quantitative MRI Is Associated With Concurrent Quantitative Cartilage Loss Over 24 Months.
介入试验应采用哪些终点指标?——从根据药物作用机制进行的单一维度评估到多组分测量和多领域综合指标
Osteoarthr Imaging. 2025 Mar;5(1). doi: 10.1016/j.ostima.2024.100256. Epub 2024 Dec 25.
4
Bone marrow lesions in osteoarthritis: Characterising genetic and histological changes to understand disease pathophysiology.骨关节炎中的骨髓病变:表征基因和组织学变化以了解疾病病理生理学。
Osteoarthr Cartil Open. 2024 Oct 26;6(4):100531. doi: 10.1016/j.ocarto.2024.100531. eCollection 2024 Dec.
关节组织损伤的恶化,如半定量 MRI 所定义的,与 24 个月内同时发生的定量软骨丢失有关。
Cartilage. 2023 Mar;14(1):39-47. doi: 10.1177/19476035221147677. Epub 2023 Jan 9.
4
Selection of Knees With Subsequent Cartilage Thickness Loss Based on Magnetic Resonance Imaging Semiquantitative Grading: Data From the Osteoarthritis Initiative Foundation for the National Institutes of Health Biomarker Cohort.基于磁共振成像半定量分级的膝关节选择及其随后的软骨厚度损失:来自美国国立卫生研究院生物标志物队列的骨关节炎倡议基金会的数据。
Arthritis Care Res (Hoboken). 2023 Aug;75(8):1773-1782. doi: 10.1002/acr.25078. Epub 2023 Feb 22.
5
Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort.结构组织损伤与 IMI-APPROACH 队列中膝关节骨关节炎半定量 MRI 生物标志物 24 个月的进展。
BMC Musculoskelet Disord. 2022 Nov 17;23(1):988. doi: 10.1186/s12891-022-05926-1.
6
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit.FDA/关节炎基金会骨关节炎药物研发研讨会纪要:长期获益评估。
Semin Arthritis Rheum. 2022 Oct;56:152070. doi: 10.1016/j.semarthrit.2022.152070. Epub 2022 Jul 14.
7
Five-Year Structural Changes in the Knee Among Patients With Meniscal Tear and Osteoarthritis: Data From a Randomized Controlled Trial of Arthroscopic Partial Meniscectomy Versus Physical Therapy.半月板撕裂和骨关节炎患者膝关节结构五年变化:关节镜部分半月板切除术与物理治疗随机对照试验数据。
Arthritis Rheumatol. 2022 Aug;74(8):1333-1342. doi: 10.1002/art.42105. Epub 2022 Jun 28.
8
Heterogeneity of cartilage damage in Kellgren and Lawrence grade 2 and 3 knees: the MOST study.Kellgren 和 Lawrence 分级 2 和 3 膝关节软骨损伤的异质性:MOST 研究。
Osteoarthritis Cartilage. 2022 May;30(5):714-723. doi: 10.1016/j.joca.2022.02.614. Epub 2022 Feb 22.
9
Composite outcomes at OMERACT: Multi-outcome domains and composite outcome domains.OMERACT 中的复合结局:多结局域和复合结局域。
Semin Arthritis Rheum. 2021 Dec;51(6):1370-1377. doi: 10.1016/j.semarthrit.2021.11.001. Epub 2021 Nov 6.
10
Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.富血小板血浆关节内注射与安慰剂注射对膝骨关节炎患者疼痛和胫骨内侧软骨体积的影响:RESTORE 随机临床试验。
JAMA. 2021 Nov 23;326(20):2021-2030. doi: 10.1001/jama.2021.19415.